Key result
Cardiovascular disease was associated with 42 differentially expressed genes in epicardial adipose tissue across 40 studies, with IL-6 and TP53 identified as main hub genes.
Why the study?
What are the differentially expressed genes in epicardial adipose tissue associated with cardiovascular diseases?
Meta-Analysis
What are the differentially expressed genes in epicardial adipose tissue associated with cardiovascular diseases?
Regulation of apoptosis in epicardial adipose tissue, particularly involving IL-6 and TP53, may play a critical role in CVD development and serve as potential biomarkers.
Answers are grounded in this paper and cite their sources.
IL-6 and TP53 merit validation as epicardial adipose tissue biomarkers; extends transcriptomic meta-analyses by prioritizing apoptosis pathways in CVD.
The objective of this study was to perform a systematic review of published literature on differentially expressed genes (DEGs) in human epicardial adipose tissue (EAT) to identify molecules associated with CVDs. A systematic literature search was conducted in PubMed, SCOPUS, and ISI Web of Science literature databases for papers published before October 2014 that addressed EAT genes and cardiovascular diseases (CVDs). We included original papers that had performed gene expressions in EAT of patients undergoing open-heart surgery. The Reporting Recommendations for Tumor Marker Prognostic Studies (PRIMARK) assessment tool was also used for methodological quality assessment. From the 180 papers identified by our initial search strategy, 40 studies met the inclusion criteria and presented DEGs in EAT samples from patients with and without CVDs. The included studies reported 42 DEGs identified through comparison of EAT-specific gene expression in patients with and without CVDs. Among the 42 DEGs, genes involved in regulating apoptosis had higher enrichment scores. Notably, interleukin-6 (IL-6) and tumor protein p53 (TP53) were the main hub genes in the network. The results suggest that regulation of apoptosis in EAT is critical for CVD development. Moreover, IL-6 and TP53 as hub genes could serve as biomarkers and therapeutic targets for CVDs.
No takes yet. Share an insight, caveat, or question.
Maghbooli et al. (2015) conducted a meta-analysis in Cardiovascular diseases (CVDs). Cardiovascular diseases (CVDs) vs. Patients without cardiovascular diseases was evaluated on Differentially expressed genes (DEGs) in epicardial adipose tissue. Cardiovascular disease was associated with 42 differentially expressed genes in epicardial adipose tissue across 40 studies, with IL-6 and TP53 identified as main hub genes.
Synapse has enriched 10 related papers. Consider them for comparative context: